Determinants of paclitaxel uptake, accumulation and retention in solid tumors

Investigational New Drugs

Volumn 19, Issue 2, 2001, Pages 113-123

  Jang, Seong H ^a   Wientjes, M Guillaume ^a   Au, Jessie L S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Effux; Paclitaxel; Penetration; Solid tumor histoculture; Uptake

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; TUBULIN; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BINDING AFFINITY; BINDING SITE; COMPUTER SIMULATION; CONCENTRATION RESPONSE; DISSOCIATION CONSTANT; DRUG ACCUMULATION; DRUG PENETRATION; DRUG RETENTION; DRUG UPTAKE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BINDING SITES; CELL MEMBRANE; DIFFUSION; HUMANS; NEOPLASMS; P-GLYCOPROTEIN; PACLITAXEL; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0035023997     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010662413174     Document Type: Article

References (38)

1. Taxol: Pharmacology, metabolism and clinical implications
2. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
3. Characterization of a human myeloid leukemia cell line highly resistant to taxol
4. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro
5. Cellular uptake and efflux of docetaxel (taxotere) and paclitaxel (taxol) in P388 cell line
6. P-glycoprotein binding and modulation of the multidrug resistant phenotype by estramustine
7. 2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer
8. High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial
9. Binding of taxol to plastic and glass containers and proteins under in vitro conditions
10. Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids
11. Slow penetration of anthracyclines into spheroids and tumors: A therapeutical advantage?
12. Relationship between the penetration, binding and average concentration of cytostatic drugs in human tumor spheroids
13. Pharmacokinetic/cytokinetic principles in the chemotherapy of solid tumours
14. Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids
15. Computational model of intracellular pharmacokinetics of paclitaxel
16. Taxol binds to cellular microtubules
17. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations
18. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death
19. Kinetics and mathematical modeling of paclitaxel efflux by p-glycoprotein in BC19 cells
20. P-glycoprotein, multidrug resistance and tumor progression
21. Biochemistry of multidrug resistance mediated by the multidrug transporter
22. The clinical applications of the histoculture drug response assay
23. Potential of the histoculture drug-response assay to contribute to cancer patient survival
24. Sponge-gel-supported histoculture drug-response assay for head and neck cancer
25. Altered expression of Mβ2. The class IIβ-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance
26. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol)
27. Mechanisms of action of and resistance to antitubulin agents: Microtubule dynamics, drug transport, and cell death
28. Taxol binds to polymerized tubulin in vitro
29. Pharmacodynamics of immediate and delayed effects of paclitaxel: Role of slow apoptosis and intracellular drug retention
30. Mulfidrug resistance in cells transfected with human genes encoding a variant p-glycoprotein and glutathione S-transferase-π
31. P-glycoprotein overexpression increases maximum induction of apoptosis by taxol
32. Determinants of paclitaxel penetration and accumulation in human solid tumor
33. A kinetic model for taxol accumulation in human cancer cells: In vivo extrapolation
34. Characterisations of taxol-induced apoptosis and altered gene expression in human breast cancer cells
35. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol
36. Paclitaxel-induced apoptosis in MCF7 breast cancer cells
37. Pharmacodynamics of taxol in human head and neck tumors
38. Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis